Research project
LE006P20
CD160 como diana terapeútica en las células citotóxicas para aumentar la respuesta inmunitaria anti-tumoral frente a tumores hematopéyicos.
date_range
Duration: from 06 November 2020 to 05 November 2023
(36 months)
Researchers
Publications related to the project
Show by yearArticle
-
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression
2023
Frontiers in Immunology
-
Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance
2022
Frontiers in Immunology